2022 | Eurofins acquired 100% shares of MGS since 1 March 2022. The company started to use the "Eurofins | Modern Genomic Services" sub-logo. Eurofins MGS has engaged in developing various new diagnostic tests to meet the local market demand.

2021 | MGS established COVID-19 RT-PCR and antibody testing services and became one of the local COVID-19 RT-PCR testing institutions recognised by the HKSAR Government.

2020 | The MGS' laboratory attained the CAP/CLIA accreditation status soon after its inception.

2019 | MGS was established in Dec 2019. It started to offer health and wellness related DNA testing services in Hong Kong and also for the market in the nearby regions.